Brokerage house Motilal Oswal is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 873, in its research report dated October 31, 2014.

Hold Glenmark Pharma; target of Rs 805: Sharekhan

Sharekhan has recommended hold rating on Glenmark Pharma with a target price of Rs 805, in its research report dated October 31, 2014.

Accumulate Glenmark Pharma; target of Rs 786: PLilladher

Prabhudas Lilladher is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 786 in its October 31, 2014 research report.

Hold Glenmark Pharma; target of Rs 805: Sharekhan

Sharekhan has recommended hold rating on Glenmark Pharma with a target of Rs 805, in its research report dated September 09, 2014.

Hold Glenmark Pharma; target of Rs 580: Sushil Finance

Sushil Finance has recommended a hold rating on Glenmark Pharma with a target price of Rs 580, in its January 29, 2014. research report.

Hold Glenmark Pharma; target Rs 580: Sushil Finance

Sushil Finance has recommended a hold rating on Glenmark Pharma with a target price of Rs 580, in its November 08, 2013 research report.

Buy Glenmark Pharma; target Rs 606: Firstcall Research

Brokerage house Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 606 in its November 04, 2013 research report.

Buy Glenmark Pharma; target of Rs 633: Motilal Oswal

Motilal Oswal has maintained buy raitng on Glenmark Pharma with a target price of Rs 633, in its September 10, 2013 reports.

Buy Glenmark Pharma; target Rs 602: Firstcall Research

Brokerage house Firstcall Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 602 in its June 21, 2013 research report.

FinQuest Securities maintains 'Hold' on Glenmark Pharma

Brokerage house FinQuest Securities has maintained its 'Hold' rating on Glenmark Pharmaceuticals with a price target Rs 536, in its May 13, 2013 research report. The stock is fairly valued at the current price and there is limited room for further upside. Expect the revenue to grow at 15% CAGR during FY13-16, said the research report.

Buy Glenmark Pharma; target of Rs 565: Firstcall Research

Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 565 in its March 18, 2013 research report.

Buy Glenmark Pharma at Rs 505-495; tgt Rs 571: ICICIdirect

ICICIdirect.com is bullish on Glenmark Pharma and has recommended to buy the stock in the range of Rs 505-495 for a target price of Rs 571 with a stop loss below Rs 465 on a closing basis, in its research report.

Buy Glenmark Pharma; target of Rs 585: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 585 in its February 1, 2013 research report.

Hold Glenmark Pharma; target Rs 536: FinQuest Securities

FinQuest Securities has recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 536, in its January 31, 2013 research report.

Hold Glenmark Pharmaceuticals; target Rs 556: Nirmal Bang

Nirmal Bang has recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 556, in its January 30, 2013 research report.

Buy Glenmark Pharma; target of Rs 608: Firstcall Research

Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 608 in its January 2, 2013 research report.

Buy Glenmark Pharma around Rs 440-428: ICICIdirect.com

ICICIdirect.com is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 520 in its November 22, 2012 research report.

Buy Glenmark Pharma; target of Rs 480: FinQuest

FinQuest Securities is bullish on Glenmark Pharma (GNP) and has recommended buy rating on the stock with a target of Rs 480 in its November 5, 2012 research report.

Buy Glenmark Pharma; target of Rs 500: Emkay

Emkay Global Financial Services is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 500 in its October 31, 2012 research report.

Hold Glenmark Pharma; target of Rs 400: Emkay

Emkay Global Financial Services has recommended hold rating on Glenmark Pharma with a target of Rs 400, in its August 03, 2012 research report.

Buy Glenmark Pharma; target Rs 395: FinQuest Securities

FinQuest Securities is bullish on Glenmark Pharma (GNP) and has recommended buy rating on the stock with a target price of Rs 395 in its May 10, 2012 research report.

Buy Glenmark Pharma; target of Rs 370: ICICIdirect.com

ICICIdirect.com is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 370 in its April 13, 2012 research report.

Buy Glenmark Pharmaceuticals; target Rs 368: Sushil Finance

Sushil Finance is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 368 in its February 9, 2012 research report.

Hold Glenmark Pharma; target of Rs 364: Nirmal Bang

Nirmal Bang has recommended hold rating on Glenmark Pharma with a target of Rs 364, in its February 1, 2012 research report.

Buy Glenmark Pharma; target of Rs 360: KRChoksey

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 360 in its February 1, 2012 research report.